Originator Organization |
Active Organization- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H16N4 |
InChIKeyVXNHTGWDWVCFSI-UHFFFAOYSA-N |
CAS Registry794510-70-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | ES | - | 23 Sep 2010 |